Risk factors for thrombosis and the beneficial effect of aspirin in patients with antiphospholipid antibodies (aPL)

被引：3
|
作者：
Hansen, KE
Kramm, HL
Boh, D
Bell, CB
Perry, S
Potti, A
Ortel, TL
机构：
[1] Univ Wisconsin, Dept Med, Madison, WI USA
[2] Duke Univ, Med Ctr, Div Hematol, Durham, NC USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.279.279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
279
引用
收藏
页码：83A / 83A
页数：1
相关论文
共 50 条
  • [1] Risk factors associated with thrombosis in patients with antiphospholipid antibodies
    Hansen, KE
    Kong, DF
    Moore, KD
    Ortel, TL
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (09) : 2018 - 2024
  • [2] Factors related to the risk of thrombosis in patients with lupus antiphospholipid antibodies and
    Martinez, Fernando
    Forner, Maria Jose
    Ruano, Maria
    Abdilla, Noelia
    Oltra, Rosa
    Garcia-Fuster, Maria Jose
    MEDICINA CLINICA, 2006, 127 (11): : 405 - 408
  • [3] Anticardiolopin antibodies as thrombosis risk factors in the treated patients with antiphospholipid
    Haroyan, A.
    Mkrtchyan, N.
    Tokhunts, K.
    Galstyan, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 145 - 145
  • [4] Should aspirin be used as a preventive therapy for thrombosis in patients with antiphospholipid antibodies?
    O'Neil, Kathleen M.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (01): : 14 - 15
  • [5] Should aspirin be used as a preventive therapy for thrombosis in patients with antiphospholipid antibodies?
    Kathleen M O'Neil
    Nature Clinical Practice Rheumatology, 2008, 4 : 14 - 15
  • [6] Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia
    Bidot, CJ
    Jy, W
    Horstman, LL
    Ahn, ER
    Bidot, L
    Fontana, V
    Ahn, YS
    HEMATOLOGY, 2005, 10 (06) : 451 - 456
  • [7] Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
    Tektonidou, Maria G.
    Laskari, Katerina
    Panagiotakos, Demosthenes B.
    Moutsopoulos, Haralampos M.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (01): : 29 - 36
  • [8] ANTIPHOSPHOLIPID (APL) ANTIBODIES IN HEMODIALYSIS-PATIENTS
    BRUNET, P
    AILLAUD, MF
    SANMARCO, M
    DUSSOL, B
    JUHANVAGUE, I
    BERNARD, D
    BERLAND, Y
    KIDNEY INTERNATIONAL, 1995, 47 (05) : 1481 - 1481
  • [9] Association of Environmental Risk Factors with Antiphospholipid Antibodies and Thrombosis in 1199 International Patients Referred for Suspected Antiphospholipid Syndrome
    Barbhaiya, Medha
    Jannat-Khah, Deanna
    Levine, Jonah
    Costenbader, Karen
    Erkan, Doruk
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1357 - 1359
  • [10] VARIATION OF ANTIPHOSPHOLIPID ANTIBODY (APL) TITERS IN PATIENTS WITH PERSISTENT ANTIPHOSPHOLIPID ANTIBODIES
    Vegas, C.
    Martinez Becerra, M. J.
    Tellez, R.
    Tramon, P.
    Rodriguez, M. J.
    Palacios, C.
    Sanchez, O.
    Serrano, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 538 - 538
12345